LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
LRIG1 is a tumour suppressor in several cancers. Here, the authors show that androgen receptor directly transactivates LRIG1 which then antagonises ERBB signalling and c-Myc expression to inhibit prostate tumorigenesis.
Guardado en:
Autores principales: | Qiuhui Li, Bigang Liu, Hsueh-Ping Chao, Yibing Ji, Yue Lu, Rashid Mehmood, Collene Jeter, Taiping Chen, John R. Moore, Wenqian Li, Can Liu, Kiera Rycaj, Amanda Tracz, Jason Kirk, Tammy Calhoun-Davis, Jie Xiong, Qu Deng, Jiaoti Huang, Barbara A. Foster, Abhiram Gokhale, Xin Chen, Dean G. Tang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/556fc4b133f24b85b14cddf5c742adf8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
por: Qiuhui Li, et al.
Publicado: (2020) -
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
por: Qiuhui Li, et al.
Publicado: (2018) -
LRIG1 is a gatekeeper to exit from quiescence in adult neural stem cells
por: María Ángeles Marqués-Torrejón, et al.
Publicado: (2021) -
LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes
por: Carl Herdenberg, et al.
Publicado: (2021) -
MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes
por: Can Liu, et al.
Publicado: (2017)